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The circulation of cerebral blood flow (CBF) is driv-en by cerebral perfusion pressure (CPP), which is defined as the vascular pressure gradient across the 
cerebral bed and can be calculated as the difference be-
tween arterial blood pressure (ABP) and pressure in cor-
tical or bridging veins.15,24 Due to difficulties in measur-
ing the pressure of bridging veins, invasive intracranial 
pressure (ICP) measurements are used instead as an ap-
proximation, defining CPP as ABP − ICP.1,26,34,39 Cerebral 
perfusion pressure in clinical practice is considered an es-
abbreviatioNs ABP = arterial blood pressure; AUC = area under the curve; CBF = cerebral blood flow; CPP = cerebral perfusion pressure; CrCP = critical closing pres-
sure; CVR = cerebrovascular resistance; eCPP = noninvasive estimator of CPP; FV = flow velocity; GCS = Glasgow Coma Scale; GOS = Glasgow Outcome Scale; ICP = 
intracranial pressure; IQR = interquartile range; MCA = middle cerebral artery; nICP = noninvasive estimator of ICP; ROC = receiver operating characteristic; TAU = time 
constant of the cerebrovascular arterial bed; TBI = traumatic brain injury; TCD = transcranial Doppler.
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obJect Cerebral blood flow is associated with cerebral perfusion pressure (CPP), which is clinically monitored through 
arterial blood pressure (ABP) and invasive measurements of intracranial pressure (ICP). Based on critical closing pres-
sure (CrCP), the authors introduce a novel method for a noninvasive estimator of CPP (eCPP).
methods Data from 280 head-injured patients with ABP, ICP, and transcranial Doppler ultrasonography measure-
ments were retrospectively examined. CrCP was calculated with a noninvasive version of the cerebrovascular imped-
ance method. The eCPP was refined with a predictive regression model of CrCP-based estimation of ICP from known 
ICP using data from 232 patients, and validated with data from the remaining 48 patients.
results Cohort analysis showed eCPP to be correlated with measured CPP (R = 0.851, p < 0.001), with a mean ± SD 
difference of 4.02 ± 6.01 mm Hg, and 83.3% of the cases with an estimation error below 10 mm Hg. eCPP accurately 
predicted low CPP (< 70 mm Hg) with an area under the curve of 0.913 (95% CI 0.883–0.944). When each recording 
session of a patient was assessed individually, eCPP could predict CPP with a 95% CI of the SD for estimating CPP 
between multiple recording sessions of 1.89–5.01 mm Hg.
coNclusioNs Overall, CrCP-based eCPP was strongly correlated with invasive CPP, with sensitivity and specificity 
for detection of low CPP that show promise for clinical use.
http://thejns.org/doi/abs/10.3171/2014.10.JNS14613
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sential monitored parameter for head-injury management 
protocols,7,9,12–14,22,23,31,33,35 even though ideal CPP has been 
poorly delineated.4,41 The invasive part of CPP calculation 
is ICP, the invasive nature of which can make the calcula-
tion of CPP and thus the CPP-oriented management unfea-
sible, such as in some clinical scenarios in which invasive 
measurement of ICP is either not available or unobtain-
able (i.e., for patients with contraindications for direct 
measurement).3,8,27 In contrast, ABP can be measured and 
monitored noninvasively,20,30,37 i.e., with a Finapres finger 
plethysmograph, the use of which has been shown to pro-
vide a good level of agreement between Finapres-derived 
indices of cerebral autoregulation and their corresponding 
estimates obtained from invasive measurements of aortic 
ABP.36
Cerebral perfusion pressure has been approximated 
noninvasively with various methodologies in the past, 
based on ABP and transcranial Doppler (TCD) ultraso-
nography approximations of CBF.2,5,10,18,38 The use of these 
methodologies is promising as their estimation accuracy 
is improving. We have created a new method for assessing 
CPP noninvasively using a model based on the concept of 
critical closing pressure (CrCP), requiring ABP and TCD 
flow velocity (FV) measurements.
Critical closing pressure denotes a threshold of ABP, 
below which the local microvascular blood pressure is in-
adequate to prevent collapse and cessation of blood flow.28 
As CrCP is associated with the vasomotor tone of small 
blood vessels, knowledge of its behavior has been recog-
nized as able to provide valuable information regarding 
the state of cerebral hemodynamics in different patholo-
gies.11,25,28,32,40 We have recently introduced a new method 
for estimating CrCP that is an apparent improvement on 
traditional methodology,25,40 in which the new, impedance 
model–based method does not render negative values.32,40 
However, this method is invasive, as ICP measurements 
are required, possibly limiting its clinical applications in 
situations in which measuring ICP is not an option. For 
this reason, an equivalent noninvasive version of this mod-
el has been introduced, which only requires measurements 
of ABP and FV. The primary aim of this study was to use 
the CrCP method for a noninvasive assessment of CPP in 
a large group of head-injured patients.
methods
patient population
The presented analysis was performed as part of an 
anonymous clinical audit, with approval of the Neurocriti-
cal Care Users Committee of Addenbrooke’s Hospital in 
Cambridge, the United Kingdom. This retrospective study 
included prospectively collected data from 280 sedated 
and ventilated patients with head injuries (78.2% male, 
median age 29 years, interquartile range [IQR] 20–43 
years), hospitalized in the Neurocritical Care Unit of Ad-
denbrooke’s Hospital between 2002 and 2011.10 The de-
mographics of the patients are summarized in Table 1. All 
patients suffered a traumatic brain injury (TBI) and had an 
abnormal CT scan of the head. Patients were sedated, ven-
tilated, and managed in the Neurocritical Care Unit with a 
tiered therapeutic protocol aiming for an ICP < 25 mm Hg 
and CPP around 60–70 mm Hg. The median preintuba-
tion Glasgow Coma Scale (GCS) score of the patients was 
6 (range 3–15), while the Glasgow Outcome Scale (GOS) 
score, assessed 6 months after injury, varied from good 
outcome to death: 144 patients (51.4%) had a favorable 
outcome (no disability to moderate disability), while 63 
patients (22.5%) died. Patients remaining in a persistent 
vegetative state (n = 9, or 3.2% of the total number of pa-
tients) were excluded from the study. The data included 
daily recordings of ABP, ICP, and TCD, performed under 
a standard clinical brain monitoring protocol, in a total of 
780 recording periods.
monitoring and data analysis
To monitor ABP, a pressure monitoring kit (Baxter 
Healthcare) at the radial artery was used, zeroed at the 
level of the heart. Monitoring of ICP was performed via an 
intraparenchymal probe (Codman & Shurtleff, or Camino 
Laboratories). Cerebral blood FV was measured from the 
middle cerebral artery (MCA) with a 2-MHz probe and 
monitored with the Doppler Box (DWL Compumedics) 
or Neuroguard (Medasonics, Inc.). The TCD recordings 
were performed on a daily basis for periods ranging from 
10 minutes up to 1 hour, starting from the day of initiation 
of invasive monitoring. Termination of the monitoring was 
decided based on clinical grounds. An analog–digital con-
verter (DT2814 or DT9801, Data Translation) was used 
to digitize the raw data signals at a sampling frequency 
of 50 Hz, which were then recorded using WREC (War-
saw University of Technology), BioSAn (University of 
Cambridge), or ICM+ (Cambridge Enterprise, http://www.
neurosurg.cam.ac.uk/icmplus/) software. Heart rate was 
calculated using spectral position of the peak associated 
with the first harmonic of ABP. All calculations, including 
mean values of ABP, ICP, FV, and CPP, were performed 
over a sliding window of 10 seconds.
calculation of Noninvasive crcp and cpp
Critical closing pressure (expressed in mm Hg) was es-
timated through a noninvasive version of the impedance 
CrCP methodology,40 based on ABP and TCD FV (see 
Appendix):
  
[Eq. 1]
CVR denotes cerebrovascular resistance, Ca expresses ar-
terial compliance of the cerebral bed, and HR represents 
heart rate (beats/sec).
To create and assess the model for the noninvasive es-
timator of CPP (eCPP), we dichotomized our set cohort 
of patients and formed 2 subgroups: the formation group 
with 232 patients (including 455 recordings) and the vali-
dation group with 48 patients (including 325 recordings).
Because the invasive part of CPP is ICP, we used the 
formation group to render a noninvasive estimator of ICP 
(nICP) based on a regression analysis of known ICP with 
CrCP (Eq. 1): nICP = 0.266 ⋅ CrCP + 7.026 (p < 0.001; R 
= 0.340, F = 59.225, N = 455). Details of the regression 
analysis are presented in Table 2.
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Following the introduction of nICP, eCPP (in mm Hg) 
can then be rendered as:
eCPP = ABP − nICP
or
 
[Eq. 2]
In this way, eCPP is associated with physiological param-
eters of CVR, compliance, and heart rate, with ABP and 
FV as the required measurements. The performance of the 
new estimator was tested by comparing eCPP against in-
vasive CPP, using data from the validation group.
The dichotomization of the total population of patients 
into 2 groups (formation and validation) was based on an 
optimization procedure for exploiting in full the avail-
able set of data. For this reason, a simple minimum re-
quirement criterion was set, in which the validation group 
included only patients with a minimum of 5 or more re-
cording sessions per patient. This selection subsequently 
dictated the number of patients to be included in the sec-
ond group, used for formation of eCPP. Dichotomizing the 
cohort of patients in this way presented 2 benefits: 1) the 
multirecording validation portion of the study allowed for 
the determination of the correlation between eCPP and 
CPP using repetitive measurements from individual pa-
tients, and 2) the high number of recordings included in 
the formation group increased the statistical power of the 
regression model, hence rendering a more accurate eCPP. 
A full overview of the terminology used in this study is 
presented in Table 3.
statistical analysis
Statistical analysis of the data was conducted with 
SPSS statistical software (version 20, IBM). The analysis 
included bivariate correlations, with R representing the 
Pearson correlation coefficient, and the level of signifi-
cance (p value) set at 0.05. Results are presented in a mean 
table 1. patient characteristics
Variable Overall Cohort Formation Group Validation Group p Value*
No. of patients 280 232 48
No. of recordings 780 455 325
Demographics
  Median age in yrs (IQR) 29 (20–43) 29 (21–46) 24 (18–37) 0.016
  Males/females 219:61 187:45 32:16
Median GCS score before intubation (IQR)  6 (4–8) 7 (4–8) 6 (4–8) 0.521
GOS score 6 mos after injury (%)
  Death 63 (22.5) 54 (23.3) 9 (18.8)
  Persistent vegetative state† — — —
  Severe disability 73 (26.1) 56 (24.1) 17 (35.4)
  Moderate disability 66 (23.6) 58 (25.0) 8 (16.7)
  Good recovery 78 (27.9) 64 (27.6) 14 (29.2)
Mean monitored signals ± SD
  ABP (mm Hg) 91.31 ± 12.15 91.09 ± 12.57 92.36 ± 9.91 0.510
  ICP (mm Hg) 17.85 ± 9.07 16.99 ± 9.29 21.98 ± 6.58 <0.001
  CPP (mm Hg) 73.46 ± 12.25 74.10 ± 12.42 70.39 ± 11.01 0.056
  FV (cm/sec) 64.08 ± 24.89 64.74 ± 25.94 60.93 ± 18.96 0.336
*  p value for comparing parameters between the formation and the validation group with independent samples t-tests.
†  Patients remaining in a persistent vegetative state were excluded from the study.
table 2. summary of regression analysis parameters*
Variable Coefficients SEM 95% CI
CrCP 0.266 0.035 0.198–0.333
Constant 7.026 1.361 4.352–9.700
*  Model summary (nICP): R = 0.340, F = 59.225, p < 0.001.
table 3. terminology of used parameters
Symbol Term Units
ABP Arterial blood pressure mm Hg
Ca Cerebral arterial compliance cm/mm Hg
CaBV Cerebral arterial blood volume cm3
CBF Cerebral blood flow cm3/sec
CPP Cerebral perfusion pressure mm Hg
CrCP Critical closing pressure  mm Hg
CrCPi Invasive model of critical closing pressure mm Hg
CVR Noninvasive cerebrovascular resistance mm Hg/(cm/sec)
CVRi Invasive cerebrovascular resistance mm Hg/(cm/sec)
eCPP Noninvasive estimator of CPP mm Hg
FV Blood flow velocity cm/sec
HR Heart rate beat/min
ICP Intracranial pressure mm Hg
nICP Noninvasive estimator of ICP mm Hg
Sa Cross-sectional area of the insonated 
vessel
cm2
TAU Time constant of the cerebrovascular 
arterial bed 
sec
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± SD format. Normal distribution was established with the 
Shapiro-Wilk test. The Bland-Altman method was used to 
determine the agreement between measured parameters 
and their noninvasive estimations. A receiver operating 
characteristic (ROC) was further used to determine the 
ability of eCPP to predict CPP, presented with areas under 
the curve (AUC); the predicting ability is considered rea-
sonable when the AUC is higher than 0.7 and strong when 
the AUC exceeds 0.8.16 The classification decision tree was 
created with the Chi-squared Automatic Interaction Detec-
tion (CHAID) growing method.
results
comparison of ecpp to measured cpp for patients as a 
cohort
When we assessed the group of patients as a cohort, the 
averaged per patient eCPP was strongly correlated with 
the invasively measured CPP (R = 0.851, p < 0.001, n = 48; 
Fig. 1 left), with a mean ± SD difference between CPP and 
eCPP of 4.02 ± 6.01 mm Hg (Fig. 1 right). In total, 83.3% 
of the cases (40 patients) had an absolute estimation error 
of eCPP to CPP below 10 mm Hg.
The eCPP maintained its estimation accuracy when we 
assessed the group of 48 patients as a cohort of recordings 
(n = 325), with a correlation to CPP of R = 0.813, a mean 
difference of 3.70 ± 8.70 mm Hg, and with 259 (79.7%) of 
325 recordings with an absolute estimation error less than 
10 mm Hg (IQR 2.47–6.09 mm Hg).
Further analysis of the recordings with a classification 
decision tree indicated the absolute estimation errors for 
various ranges of CPP: for CPP greater than 80.19 mm Hg, 
the absolute estimation error of eCPP was 4.31 ± 2.86 mm 
Hg (97 recordings), followed by a range of CPP between 
63.01 and 80.19 mm Hg, which had an absolute estimation 
error of 5.55 ± 4.26 mm Hg (131 recordings). The distribu-
tion of the absolute error of eCPP - CPP across the range 
of CPP values is demonstrated in Fig. 2.
low cpp prediction analysis
An ROC curve analysis was used to determine the abil-
ity of eCPP to predict a low value of CPP in 325 record-
ings. Three different limits were set for CPP: 50, 60, and 
70 mm Hg (Table 4). In this analysis, eCPP accurately 
predicted low CPP, with an AUC greater than 0.8 for all 3 
limits (Table 4, Fig. 3).
temporal analysis of ecpp as an estimator of invasive 
cpp
In temporal analysis, each patient was assessed indi-
vidually, rendering an individual correlation coefficient 
and a mean ± SD difference of eCPP from CPP between 
recording sessions. These individual results were then av-
eraged for all patients in the application group, resulting 
in an eCPP that was found to be strongly correlated with 
CPP (mean R = 0.733, range 0.231–0.993). Examples of in-
dividual correlations between eCPP and CPP for patients 
are presented in Fig. 4.
For each patient, eCPP presented a mean difference 
from CPP of 3.45 mm Hg (range -4.69 to 19.03 mm Hg), 
and a mean SD of this difference of 5.52 mm Hg (range 
1.52–10.76 mm Hg). These data imply a 95% CI of the SD 
for estimating CPP within 1 recording session of a patient 
to be 1.89–5.01 mm Hg.
Examples of how eCPP approximates changes of CPP 
in various scenarios captured during recording sessions of 
patients with TBI are presented in Fig. 5. Figure 6 further 
demonstrates in detail how the calculation of eCPP is af-
fected by changes in its input parameters, consisting of 
monitored signals and estimated modules, during an event 
of arterial hypotension in a recording session of a single 
patient.
discussion
We have constructed a new model for a noninvasive as-
sessment of CPP based on CrCP, requiring only ABP and 
TCD measurements, the combination of which is attempt-
Fig. 1. left: Scatterplot showing the correlation of the noninvasive methodology for assessing CPP, noted as eCPP, with mea-
sured CPP.  right: Bland-Altman plot for comparing differences between CPP and eCPP for average values of CPP and eCPP. 
Each point represents 1 patient. Outer thick lines represent the 95% CI.
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ing to compensate for exclusion of invasive ICP measure-
ments. Assessing CPP noninvasively can be beneficial in 
many clinical scenarios in which ICP monitoring is not 
indicated or is unavailable: 1) in patients with borderline 
indications for invasive ICP measurements based on Brain 
Trauma Foundation guidelines;7 2) in patients with coagu-
lopathy in trauma/hepatic encephalopathy; and 3) in poly-
trauma patients in an emergency, where a rapid assessment 
of CPP status is required during treatment of other injuries.
The basis of the new CPP estimator lies in a complex 
mathematical model, which takes into account physiologi-
cal parameters derived from ABP and FV signals, such 
as cerebrovascular compliance, resistance, and heart rate. 
The formation of eCPP methodology required an interim 
step of assessing ICP with a noninvasive predictor model, 
built with the use of a regression analysis with CrCP.
The validation of eCPP presented in this study included 
comparison analysis relative to invasively measured CPP, 
both at a level of a cohort analysis and at an individual 
level in which each patient’s monitoring session was ex-
amined individually across time.
cerebral perfusion pressure as a Number
Many clinical protocols for post–head-injury manage-
ment are focused on guidelines requiring a range or an 
optimum value of CPP that needs to be achieved for an 
adequate perfusion of the brain.7,9,12–14,22,23,31,33,35 For this 
reason, we sought to determine the accuracy of estimating 
CPP as a number by examining the group of patients as an 
averaged cohort.
The results indicated that measurements obtained with 
eCPP were highly correlated with those for invasive CPP, 
with a mean ± SD difference from CPP of 4.02 ± 6.01 mm 
Hg. In terms of absolute error, CPP was estimated by eCPP 
with an error margin below 10 mm Hg in more than 80% 
of the analyzed cases, with eCPP demonstrated to be most 
accurate in the CPP range of 60 to 90 mm Hg (Fig. 2). 
Even though there is a lack of consensus regarding the ide-
al range of CPP after TBI, and the error difference of more 
than 10 mm Hg may or may not be clinically relevant de-
pending on the duration of such a discrepancy,4,41 both the 
normal CPP range of 70–85 mm Hg41 and suggestions for 
maintaining a CPP of at least 70 mm Hg after head injury,35 
or between 50 and 70 mm Hg,7 or at a static autoregula-
tion range (i.e., 60–70 mm Hg)12 are within the range of the 
highest accuracy of eCPP. This ability of eCPP to estimate 
CPP most accurately at an expected or suggested level of 
CPP seems promising for clinical use of the method.
The outcome of a patient following TBI has been 
known to be significantly affected by exposures to sec-
ondary insults such as systemic hypotension or intracra-
nial hypertension, which can result in severely reduced 
Fig. 2. Scatterplot showing the distribution of absolute error of CPP − eCPP across the range of CPP values, with each point 
representing 1 recording session (325 recordings in total). Estimation of CPP is shown to be most accurate in the range of 60 to 90 
mm Hg, presented with decreasing absolute difference to CPP.
table 4. comparison of predictive power of ecpp for  
different levels of cpp, as assessed with roc curve analysis and 
presented with auc
CPP Limit (mm Hg) eCPP AUC (95% CI)
<50 0.905 (0.860–0.950)
<60 0.889 (0.849–0.929)
<70 0.913 (0.883–0.944)
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CPP and cerebral ischemia6,29 when CPP decreases below 
50–60 mm Hg.41 The eCPP demonstrated a strong ability 
to predict low values of CPP, as examined in 3 different 
thresholds for CPP values below 50, 60, and 70 mm Hg. 
Therefore, this signifies that eCPP could act as a nonin-
vasive indicator of potentially inadequate CPP, acting as a 
warning for hypoperfusion during monitoring of a patient.
cerebral perfusion pressure as a time-varying variable
Apart from assessing CPP solely as a number, some 
studies suggest that CPP is better considered as a condi-
tion of CBF, reflecting the hemodynamic status of a patient 
after TBI.10,21,37 This suggestion is based on the fact that 
in clinical practice, brain perfusion assessed through CPP 
can be underestimated due to ABP monitoring devices 
Fig. 3. ROC curve analyses for predicting low CPP with eCPP for 2 different thresholds of CPP: 50 mm Hg (left) and 70 mm Hg 
(right). In both cases, eCPP demonstrated a strong predictive power, indicated by the AUC values.
Fig. 4. Examples of individual correlations between CPP and eCPP. Each graph represents 1 patient and each open circle repre-
sents 1 recording session. The upper row (a–c) demonstrates cases of good correlations between CPP and eCPP, whereas the 
lower row (d–F) presents the weaker cases. Weaker cases are associated with overestimation of CPP.
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measuring readings from peripheral vessels and calibrated 
at the heart level and not at the head level.10 Therefore, 
brain perfusion is better represented by global CBF as-
sessed through MRI or PET, instead of a numerical value 
of CPP. However, these existing methods for accurately as-
sessing CBF are not suitable for continuous monitoring,37 
the role of which is thereby served by CPP. A CPP that is 
considered not only as a value but rather as a time vari-
able can then indicate changes in CBF over time, therefore 
being able to characterize changing hemodynamic needs, 
such as in cases of arterial hypotension or intracranial hy-
pertension insults that would threaten to reduce CBF.
In this part of our study, each patient was assessed in-
dividually, with the accuracy levels of eCPP improving in 
comparison with the respective cohort analysis (mean ± 
SD differences from CPP of 3.45 ± 5.52 mm Hg vs 4.02 ± 
6.01 mm Hg, respectively). This finding implies that eCPP 
provides a more accurate CPP estimation when CPP is as-
sessed over time, i.e., for following changes in CPP during 
a monitoring session when ABP and TCD measurements 
are performed. The underlying factors for this difference 
might have to do with how ABP- and TCD-derived in-
formation is being exploited; in cohort analysis the infor-
mation regarding ABP and FV dynamics, as contained in 
CrCP, is averaged out, thereby potentially “hiding” phe-
nomena that could influence CPP for a short period of 
time. In contrast, in time analysis these phenomena, such 
as a drop in ABP, are captured, therefore improving the ac-
curacy of eCPP. This was further demonstrated in the ex-
amples shown in Fig. 5, in which eCPP correctly depicted 
a variety of changes and fluctuations of CPP.
the role of icp
Intracranial pressure has an important role in TBI man-
agement, as phenomena of intracranial hypertension can 
lead to a decrement in CPP and a potential decrease in 
CBF, causing secondary ischemic insults.15,23,26,39 In fact, 
many of the studies recommending CPP thresholds are 
confounded by high ICP, therefore further signifying its 
clinical role. However, focusing solely on ICP would not 
be sufficient, as from a physiological viewpoint, both in-
dividual components of CPP (ICP and ABP) have been 
shown to affect CBF and consist of independent predic-
tors of outcome after TBI.6,15,29,31,39 Hence, monitoring and 
management of CPP will remain one of the cornerstones 
of TBI management, even though it is recognized that fur-
ther work is required in terms of patient-specific thresh-
olds.4,41 For this reason, the development of noninvasive 
methods to monitor CPP is reasonable and could provide 
an additional option in resource-limited settings or for pa-
tients who have contraindications for invasive monitoring.
The invasive character of ICP has also been the limiting 
factor for these noninvasive CPP assessments, with high 
ICP resulting in overestimation of CPP. Therefore, infor-
mation derived from both ABP and TCD measurements 
is being used, attempting to compensate for the absence 
of invasive ICP measurements.2,5,10,18,38 In contrast to other 
methodologies, the basis of the eCPP method consists of a 
regression analysis, constructed with a large number of TBI 
recordings (455 in total), which included cases in which ICP 
is either low (5 mm Hg) or very high (above 40 mm Hg). In 
this matter, eCPP contains some TCD- and ABP-derived 
descriptive information about these cases, encapsulated 
in the form of cerebrovascular compliance and resistance 
in CrCP. This aided eCPP in capturing circumstances of 
low and very low CPP, demonstrated with high levels of 
sensitivity and specificity for detecting reduced CPP. Even 
though high ICP does cause a CPP overestimation by eCPP, 
restricting its capability in terms of estimating CPP as an 
absolute number, the loss of precision at high ICP is miti-
gated by its ability to detect low CPP.
Benefits of Using CrCP for CPP Estimation
A benefit of using impedance CrCP for estimating CPP 
Fig. 5. Examples of how CPP was approximated by eCPP in various 
CPP-affecting phenomena that occurred during monitoring. In all cases, 
changes in CPP are depicted by eCPP.  a: Incidental decrease in ABP 
causing a temporal rise in ICP and a reduction in CPP and blood FV. b: 
Arterial hypotension resulting in a decrement of CPP and FV with un-
changed ICP. c: Fluctuations of CPP. 
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is that it allowed us to associate the CPP estimator with 
further physiological parameters such as heart rate and 
measures of the resistance and compliance of the cerebro-
vascular bed. eCPP subsequently contains the product of 
CVR and compliance, relating eCPP to the physiological 
measurement of TAU, which is an estimate of how fast the 
cerebral arterial bed is filled by blood volume after a sud-
den change in ABP during 1 cardiac cycle.19 Due to this 
relationship, eCPP as a function of TAU and heart rate 
can then take into account changes in primary variables 
describing cerebral hemodynamics and cardiac function, 
enhancing its physiological presence for estimating CPP.
A further advantage of having TAU in the eCPP for-
mula is the inherited independence of eCPP from the 
unknown cross-sectional area of the insonated vessel, as 
it gets eliminated through TAU calculation (see Appen-
dix).19
limitations of the study
The calculations regarding CrCP and consequently 
eCPP depended on information derived from ABP and 
FV. Measurement and monitoring of these 2 parameters 
pose some limitations in regard to the accuracy of the es-
timations. First, a good quality of recording is required, 
and in regard to the TCD technique, the quality depends, 
among other parameters, on the experience of the user 
for accurately insonating the targeted artery (the MCA). 
Moreover, unlike ABP measurements, TCD monitoring 
was not continuous but instead it included short recording 
periods for every patient on a daily basis, therefore posing 
a restriction on continuous eCPP assessment. The reasons 
behind short recordings were: 1) the needs of a neuro-
intensive care environment, in which treatment of head-
injured patients includes change in position or transfer 
(for CT/MRI scan purposes) resulting in an unavoidable 
interruption of TCD recordings; and 2) the limitations of 
the current TCD technology, regarding the limited capa-
bility of probe holders, which are not well suited for pro-
longed continuous recording. An expected improvement 
in TCD technology for continuous FV monitoring would 
allow full exploitation of the eCPP methodology in the 
future (http://www.prnewswire.com/news-releases/physio 
sonics-announces-fda-clearance-for-presto-1000-flow-
monitor-for-ultrasound-cranial-monitoring-184153001.
html).
The use of radial artery ABP zeroed at the level of the 
heart instead of actual blood pressure in the brain could be 
considered a limitation of the study, in terms of how well 
the level of peripheral ABP can approximate the respec-
tive intracranial ABP. Heart-level calibration leads to an 
overestimation of actual CPP at the head level,17 with this 
difference also affecting the impedance calculation that de-
rives information from ABP measurements. However, this 
limitation may not have been too significant in this study 
because the primary comparisons between the invasive 
(CPP) and noninvasive calculations had a common basis, 
the same ABP point of measurement. Therefore, this limi-
Fig. 6. Example of how monitored signals and estimated parameters affect the calculation of eCPP during an event of arterial 
hypotension (gray area) in a recording session of a single patient. Monitored signals included ABP, TCD blood FV, and ICP, while 
estimated parameters included CPP, CVR, compliance (Ca), and time constant (TAU). A decrease in ABP with an increase in heart 
rate (HR) is followed by compensatory vasodilatation, reducing CVR and increasing compliance, which in turn leads to an increase 
in TAU and a reduction in CrCP due to decreased vasomotor tone of the small cerebral vessels. Overall, changes in the variables 
of the eCPP formula (see Appendix) ABP, HR, CVR, and compliance (or TAU being the product of the latter 2 variables) led to 
eCPP presenting an estimated decrease in CPP.
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tation may not have affected the actual aims of this study; 
as long as the same level of ABP measurement is used, a 
similar estimation accuracy of CPP can be expected.
The comparison of eCPP with CPP could also be ap-
plied to a comparison between invasive ICP and nICP, as 
mathematically the two models (nICP and eCPP) differ 
only in terms of the addition of ABP in eCPP. However, 
even though the accuracy levels for CPP estimation are 
promising, a similar accuracy for ICP may not be ade-
quate, due to the difference in magnitude between CPP 
and ICP. An estimation error of 5–10 mm Hg could be 
clinically acceptable for CPP, ranging, for example, from 
60 to 90 mm Hg, but would not be sufficient for an ICP 
ranging from 5 to 25 mm Hg. Even though this would 
limit the use of CrCP for noninvasive ICP estimation, it 
allowed the formation of the eCPP model, which rendered 
encouraging results for its use in clinical practice.
The number of patients in whom the eCPP method-
ology was applied might pose a limitation in this study, 
regarding the coverage of different clinical scenarios with 
a small sample consisting of 48 patients. However, these 
patients had a high number of repetitive measurements (≥ 
5 per patient), therefore fulfilling the purpose of the co-
hort’s dichotomization regarding the validation of eCPP 
as an accurate estimator of CPP, examined as a time-vary-
ing variable. An overall synopsis of the advantages and 
limitations of using eCPP is presented in Table 5.
conclusions
The use of CrCP formed the basis of a new methodol-
ogy that demonstrated promising results in regards to a 
noninvasive estimation of CPP. Analysis of patients as a 
cohort and through individual recording sessions resulted 
in a strong correlation between eCPP and CPP, presenting 
a relatively small estimation error. Most importantly, low 
values of CPP were well detected by eCPP, which showed 
strong predictive power and the ability to act as a noninva-
sive indicator of low or inadequate perfusion.
appendix
calculation of Noninvasive critical closing pressure 
(crcp)
The basis for the noninvasive model is given by the invasive 
multiparameter impedance method:39
 
[Eq. A]
In this model, the invasive parts of the formula (containing the 
ICP parameter) are CPP and invasive cerebrovascular resistance 
(CVRi), which can be approximated as:20 
In this equation, the parameter Sa in the denominator represents the 
unknown cross-sectional area of the insonated vessel. 
Ca denoting the compliance of the cerebrovascular bed can be 
estimated as:20 
In this equation, A1 is the fundamental harmonic amplitude of ABP, 
whereas CaBV1 is the amplitude of the fundamental harmonic of 
cerebral arterial blood volume (CaBV), derived by using a 10-sec-
ond discrete Fourier transformation of CaBV’s time series. Changes 
of pulsatile CaBV in turn can be approximated by integrating the FV 
pulse waveform with the beat-to-beat mean removed, in the form of 
samples of instant and average values of FV, respectively:20
In this equation, n is the number of the samples and Δt is the time 
interval between 2 consecutive samples. Instant (sampled) arterial 
blood flow velocity is represented by FV(i), while mean FV repre-
sents the corresponding average value.
By having the product of Ca and CVRi in Eq. A, the parameter 
Sa is cancelled out, as has been described in the impedance meth-
odology.39
table 5. advantages and disadvantages of using ecpp
Advantages
The estimation error of eCPP is relatively small, hence being able to provide an indication of CPP levels where invasive measurements are not avail-
able
eCPP is strongly correlated with invasive CPP, presenting a good indication of changes in CPP over time
Low values of CPP are well detected by eCPP, highlighting its ability to act as a noninvasive indicator of low or inadequate perfusion
Even though there is a lack of consensus regarding an ideal range of CPP after TBI, all the guideline levels are within the range of highest accuracy of 
eCPP
eCPP has a physiological substance, as its estimation is based on physiological parameters of heart rate, cerebrovascular resistance, compliance, 
and cerebral time constant 
eCPP is not affected by a common limitation of measuring blood flow through TCD ultrasonography as its calculation is independent of the unknown 
cross-sectional area of the insonated vessel, i.e., the MCA during measurement periods
Disadvantages
Requires TCD measurements that are hard to obtain continuously for long-term monitoring of eCPP
Requires suitable software for a next-to-bed instant calculation, based on the monitored signals of ABP and FV
High ICP causes a CPP overestimation by eCPP, restricting its capability in terms of estimating CPP as an absolute number. However, the loss of 
precision at high ICP is mitigated by eCPP’s ability to detect low and very low CPP
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In order to create the noninvasive version of CrCPi, we approx-
imate CPP with ABP and thus CVRi can be now approximated 
noninvasively as:11
Based on these remarks, the noninvasive model of impedance 
CrCP (in mm Hg) is given as:
 
[Eq. B]
association of ecpp with tau 
The product of cerebrovascular resistance (CVR) and com-
pliance (Ca) represents the noninvasive time constant, or TAU. 
Therefore, the formula for eCPP (in mm Hg) (Eq. 2 in main text) 
can be expressed as:
 [Eq. C]
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